CA2153787C - Solution renfermant igf-1 - Google Patents

Solution renfermant igf-1 Download PDF

Info

Publication number
CA2153787C
CA2153787C CA002153787A CA2153787A CA2153787C CA 2153787 C CA2153787 C CA 2153787C CA 002153787 A CA002153787 A CA 002153787A CA 2153787 A CA2153787 A CA 2153787A CA 2153787 C CA2153787 C CA 2153787C
Authority
CA
Canada
Prior art keywords
igf
mmol
solution according
buffer
stable solution
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA002153787A
Other languages
English (en)
Other versions
CA2153787A1 (fr
Inventor
Ebba Florin-Robertsson
Jonas Fransson
Diane Moore
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9300105A external-priority patent/SE9300105D0/xx
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of CA2153787A1 publication Critical patent/CA2153787A1/fr
Application granted granted Critical
Publication of CA2153787C publication Critical patent/CA2153787C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA002153787A 1993-01-15 1994-01-10 Solution renfermant igf-1 Expired - Fee Related CA2153787C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SESE9300105-5 1993-01-15
SE9300105A SE9300105D0 (sv) 1993-01-15 1993-01-15 Stable protein solution
PCT/SE1994/000010 WO1994015584A1 (fr) 1993-01-15 1994-01-10 Solution contenant l'igf-1

Publications (2)

Publication Number Publication Date
CA2153787A1 CA2153787A1 (fr) 1994-07-21
CA2153787C true CA2153787C (fr) 2005-11-15

Family

ID=35520888

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002153787A Expired - Fee Related CA2153787C (fr) 1993-01-15 1994-01-10 Solution renfermant igf-1

Country Status (1)

Country Link
CA (1) CA2153787C (fr)

Also Published As

Publication number Publication date
CA2153787A1 (fr) 1994-07-21

Similar Documents

Publication Publication Date Title
KR100482703B1 (ko) 안정한 테리파라타이드 용액
US5096885A (en) Human growth hormone formulation
US7550434B2 (en) Stabilized teriparatide solutions
JP4353544B2 (ja) アミリン作動薬ペプチド用製剤
AU676882B2 (en) Solution containing IGF-1
US20020061838A1 (en) Peptide pharmaceutical formulations
CA2315103A1 (fr) Teriparatide cristalline
US20060074011A1 (en) Compositions providing for increased IGF-I solubility
JP2002510653A (ja) 緩衝剤としてコハク酸を含有する注射可能なｉｇｆ処方物
CA2153787C (fr) Solution renfermant igf-1
JP3555961B2 (ja) 安定なペプチド医薬組成物
EP1028748B1 (fr) Compositions pour obtenir une solubilite amelioree du facteur igf-i
WO1995034318A1 (fr) Solution comprenant un facteur de croissance de type i proche de l'insuline ou tout autre analogue fonctionnel et methode de preparation
WO1997007816A1 (fr) Solution contenant l'igf-i
KR20240110601A (ko) Hgh 융합단백질의 고농도 투여 제형
MXPA00005655A (en) Stabilized teriparatide solutions
AU2003213511A1 (en) Stabilized Teriparatide Solutions

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed